Karo Pharma: Karo Pharma Aktiebolag's application for de-listing has been approved
STOCKHOLM, Nov. 11, 2022 /PRNewswire/ -- Karo Pharma Aktiebolag's ("Karo Pharma" or the "Company") application for de-listing has now been approved by Nasdaq. The last day of trading in Karo Pharm...
Read full article »
Karo Pharma is a Sweden-based pharma company that develops, produces and markets medicinal drugs for the treatment of nuclear receptors.
Read more